(Q41959515)

14 October 2017

The impact of Skp2 overexpression on recurrence-free survival following radical prostatectomy (English)

1 reference

14 October 2017

1 reference

8

Massimo Loda

1 reference

14 October 2017

Paul L Nguyen

1

1 reference

14 October 2017

Douglas I Lin

2

1 reference

14 October 2017

Junyi Lei

3

1 reference

14 October 2017

Michelangelo Fiorentino

4

1 reference

14 October 2017

Elke Mueller

5

1 reference

14 October 2017

Michael H Weinstein

6

1 reference

14 October 2017

Michele Pagano

7

1 reference

14 October 2017

17 May 2009

1 reference

14 October 2017

1 reference

14 October 2017

29

1 reference

14 October 2017

302-308

1 reference

14 October 2017

3

1 reference

Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial

14 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5437980

Oncogenic properties and prognostic implications of the ubiquitin ligase Skp2 in cancer

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5437980

The mTOR inhibitor rapamycin down-regulates the expression of the ubiquitin ligase subunit Skp2 in breast cancer cells

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5437980

The expression of the ubiquitin ligase subunit Cks1 in human breast cancer

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5437980

Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5437980

Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5437980

Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5437980

p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5437980

SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5437980

p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5437980

Natural history of progression after PSA elevation following radical prostatectomy

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5437980

Low p27 expression predicts poor disease-free survival in patients with prostate cancer

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5437980

Preoperative p27 status is an independent predictor of prostate specific antigen failure following radical prostatectomy

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5437980

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5437980

Inverse relationship between Skp2 ubiquitin ligase and the cyclin dependent kinase inhibitor p27Kip1 in prostate cancer

18 August 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.03.022

MIB-1 (KI-67) Proliferation Index and Cyclin-Dependent Kinase Inhibitor p27Kip1 Protein Expression in Nephroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.03.022

Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.03.022

Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.03.022

10.1016/J.UROLONC.2009.03.022

7 January 2021

Identifiers

DOI

1 reference

release_6txcxaabpjbbje4x6nwlayjcte

14 October 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6txcxaabpjbbje4x6nwlayjcte

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

14 October 2017

1 reference